Bayer Roundup Settlement: Judge Approves $7.25 Billion Payout for Cancer Patients

A judge has approved one of the largest mass-tort settlements in American history. St. Louis Circuit Judge Timothy Boyer granted final approval on Friday to Bayer’s $7.25 billion nationwide class settlement over claims that its Roundup weedkiller causes cancer. The judge called the total “among the largest in the history of mass tort personal-injury class action settlements”. The approval order is subject to appeal.

ताजे अपडेट पाने के लिये हमारे ग्रुप को ज्वाइन करें Join Now

Under the deal, Bayer — which acquired Roundup maker Monsanto — will make declining capped annual payments for up to 21 years, totalling up to $7.25 billion. Individual payouts will range from $10,000 to $165,000 for people who developed non-Hodgkin lymphoma after Roundup exposure, depending on how much they used it, their age at diagnosis and the severity of their illness. The settlement covers both current claimants, exposed before 17 February 2026, and future claimants diagnosed with non-Hodgkin lymphoma within a 16-year period after final approval. It also includes $600 million in attorneys’ fees.

A decade of litigation

The Roundup litigation has weighed on Bayer for close to a decade, and chief executive Bill Anderson called the approval “a decisive milestone”. The ruling follows the US Supreme Court’s 7-2 Durnell decision in June, which limited failure-to-warn cases against the company. For the market backdrop to the week, see Nasdaq plunges 5.28% as S&P 500 enters correction, and for the week’s other big court ruling, see Bill 21 Supreme Court ruling due 27 November.